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irectional migration moves cells rapidly between
points, whereas random migration allows cells to
explore their local environments. We describe a
Rac1 mechanism for determining whether cell patterns of
migration are intrinsically random or directionally persis-
tent. Rac activity promoted the formation of peripheral
lamellae that mediated random migration. Decreasing
Rac activity suppressed peripheral lamellae and switched
the cell migration patterns of ﬁbroblasts and epithelial
cells from random to directionally persistent. In three-
D
 
dimensional rather than traditional two-dimensional cell
culture, cells had a lower level of Rac activity that was as-
sociated with rapid, directional migration. In contrast to
the directed migration of chemotaxis, this intrinsic direc-
tional persistence of migration was not mediated by
phosphatidylinositol 3
 
 
 
-kinase lipid signaling. Total Rac1
activity can therefore provide a regulatory switch be-
tween patterns of cell migration by a mechanism distinct
from chemotaxis.
 
Introduction
 
Cell migration is essential for normal embryonic development,
immune system function, and tissue repair, but it also contrib-
utes to inflammatory diseases and tumor cell invasion (Lauffen-
burger and Horwitz, 1996; Ridley et al., 2003; Raftopoulou and
Hall, 2004). Both the speed and the directionality of cell motil-
ity regulate migration, which is a complex process that includes
the formation of membrane protrusions termed lamellipodia and
lamellae at the leading edge of the cell to mediate forward ad-
vancement of the cell, membrane adhesive interactions with the
migratory substrate, and coordinated dynamics of the cytoskel-
eton (Lauffenburger and Horwitz, 1996; Sheetz et al., 1999;
Pollard and Borisy, 2003; Ridley et al., 2003).
Directional migration (i.e., cell motility in one direction)
can involve either externally directed migration during chemo-
taxis or the intrinsic propensity of cells to continue migrating in
the same direction without turning (i.e., intrinsic persistence of
migration). Directional migration appears to be regulated by
multiple mechanisms, including microtubules (Vasiliev et al.,
1970; Goldman, 1971; Dujardin et al., 2003), Cdc42 (Nobes
and Hall, 1999; Etienne-Manneville and Hall, 2003), integrins
(Danen et al., 2005), and chemotactic stimuli (Haugh et al.,
2000; Franz et al., 2002; Weiner, 2002). Chemotaxis imposes
faster “directed migration” on cells through local activation of
Rac or Ras by an external chemical or protein signal, activation
of phosphatidylinositol 3
 
 
 
-kinase (PI3K), and establishment of
a phosphoinositide gradient (Srinivasan et al., 2003; Sasaki et
al., 2004; Van Haastert and Devreotes, 2004).
However, many migratory processes in development and
tissue remodeling occur with no evidence of extrinsic che-
motactic signaling, but instead by using intrinsic cell migra-
tion properties (Trinkaus, 1969). Rac and Rho are well-known
modulators of various types of cell migration including chemo-
taxis, but their role in regulating intrinsic persistence and direc-
tionality of migration is not clear (Evers et al., 2000; Chung et
al., 2000; Etienne-Manneville and Hall, 2002; Fukata et al.,
2003; Ridley et al., 2003; Burridge and Wennerberg, 2004;
Raftopoulou and Hall, 2004; Weiss-Haljiti et al., 2004).
In this study, we examined the following fundamental
question: Is there a basic, intrinsic cellular mechanism that
regulates whether a cell will migrate relatively straight ahead
or in randomly changing directions? That is, what intracellular
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signaling mechanism determines whether a cell has an intrinsic
pattern of directionally persistent migration or random, explor-
atory migration? We find that a relatively small change in total
Rac activity can serve as a switch between these two patterns
of cell migration in multiple cell types. Moreover, culturing
fibroblasts in a three-dimensional (3D) compared with a two-
dimensional (2D) environment was found to modulate Rac ac-
tivity and change intrinsic directionality of cell migration.
 
Results
 
Integrin signaling, Rac, and migration
 
A potential mechanism for regulating intrinsic cell migration
involving Rac was identified in our ongoing studies of an inte-
grin point mutation that selectively affects an Akt–PKB pathway
(Pankov et al., 2003). Fig. 1 shows that this specific integrin mu-
tation also selectively suppresses downstream Rac activity,
which is accompanied by a substantial suppression of random
motility and enhanced persistence of migratory directionality.
Specifically, Rac-GTP levels were decreased by 75% with no
differences in total Rac protein (Fig. 1 A).
Loss of random motility and increased directionality of
migration can be quantified by determining the ratio of the
shortest, linear distance from the starting point of a time-lapse
recording to the end point (D) compared with the total distance
traversed by the cell (T). This D/T directionality ratio was in-
creased by 
 
 
 
2.8-fold in cells expressing the mutant integrin
(Fig. 1, B and C; P 
 
 
 
 0.0001), accompanied by a 45% decrease
in the velocity of cell migration. The striking loss of random
motility in the integrin mutant cells was confirmed using a mean
square displacement assay (Gail and Boone, 1970; Fig. S1 A,
available at http://jcb.org/cgi/content/full/jcb.200503152.DC1).
Notably, this loss of random cell motility associated with de-
creased Rac activity was not accompanied by any detectable
change in either Cdc42 or Rho activity (Fig. 1 A).
Stable transfection with constitutively activated Akt com-
pensated for the defect in Akt signaling and corrected most of
the deficiency in active Rac (Fig. 1 D). Restoring levels of ac-
tive Rac substantially decreased directionality and promoted
random motility (Fig. 1 E). Transfection of mutant cells with
low levels of constitutively activated Rac1 also restored ran-
dom motility (Fig. S1, B and C), although higher levels proved
inhibitory and cytotoxic (not depicted).
 
Small changes in Rac activity alter 
pattern of cell migration
 
To directly test the role of total Rac activation levels in regulat-
ing the directionality of cell migration in a range of differ-
ent cell types, levels of Rac1 were knocked down using RNA
 
Figure 1.
 
Integrin mutation inhibits Rac signaling and suppresses random
cell motility. 
 
(A) GD25 cells with a point mutation in the 
 
 
 
1
 
 integrin cyto-
plasmic domain (W775A) have a selective defect in Rac activation. Activ-
ities in pull-down assays for Rac-GTP, Cdc42-GTP, and Rho-GTP and total
amounts of each protein in lysates of cells cultured on 1 
 
 
 
g/ml fibronectin
were analyzed using antibodies against Rac, Cdc42, and Rho. Densitom-
etry for each GTP-bound protein was normalized to the amount of the total
protein, and results are presented as fold change compared with cells ex-
pressing wild-type integrin. The reduction of active Rac was 75% (P 
 
 
 
0.0001), whereas active Cdc42 and active Rho were not significantly re-
duced (by 10%, P 
 
  
 
0.31 and 8%, P 
 
  
 
0.79, respectively). In this and
subsequent figures, all adjacent gel lanes are from the same gel and blot,
but their order may be rearranged for clarity as indicated by white lines
between the lanes. (B) Representative examples of migration tracks of cells
expressing wild-type 
 
 
 
1
 
 (
 
 
 
1
 
wt) or mutant (W775A) integrins cultured on fi-
bronectin and tracked for 12 h. In these and subsequent composite migra-
tion figures, randomly selected individual migration tracks were copied
and combined into a single figure to avoid empty spaces. Bar, 100 
 
 
 
m.
(C) Quantification of the persistence of migratory directionality and veloc-
ity. Cell movements were recorded by time-lapse video microscopy and
quantified by MetaMorph software. D/T ratios represent the ratio of the
direct distance from start to end point [D] divided by the total track dis-
tance [T]. Motility was calculated as velocity (
 
 
 
m/h). Data were pooled
from four independent experiments; error bars indicate SEM based on 
 
n
 
 
 
 
 
42–45 cells. (D) Activated Akt can restore Rac activity. W775A cells were
transfected with constitutively activated Akt, and stable clones were se-
lected by serum starvation for 1 wk to induce apoptosis in cells with low
Akt activity. The activity of Akt in the isolated clones (Akt clones 1–3) was
assayed by immunoblotting with antibodies against phosphorylated Akt
(p-Akt). Densitometry values for phospho-Akt were normalized to actin in
the lysates, and the changes were calculated as fold increases compared
with the parental W775A cells. The activity of Rac in the isolated Akt
clones was calculated as the fold increase above W775A cell values after
normalization of densitometry of the pull-down samples (Rac-GTP) to the
total Rac in the lysates. (E) Activated Akt restores random motility. Quanti-
fication of cell movements of the Akt clones was performed as described
in C. The decreases in D/T ratio after activated Akt expression were all
significant (Akt clone 1, P 
 
 
 
 0.01; clone 2, P 
 
 
 
 0.001; and clone 3, P 
 
 
 
0.001), as were the decreases in velocity (clone 1, P 
 
 
 
 0.01; and clones
2 and 3, P 
 
 
 
 0.001). Error bars indicate SEM. 
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interference with small interfering (si) RNA. Reductions in
Rac protein levels resulted in proportional changes in Rac ac-
tivity (Fig. S2 [available at http://jcb.org/cgi/content/full/
jcb.200503152.DC1] and not depicted). No effects of Rac1
knockdown on Cdc42 were detected, and Rho activity levels
were generally unchanged (Fig. 2 A). Random cell migration
was suppressed by such Rac1 knockdown in primary human fi-
broblasts, which is consistent with our findings in mouse ES
cell–derived GD25 cells. The cells displayed increased direc-
tionality of migration, and suppression of overall velocity oc-
curred only with a greater extent of Rac knockdown (Fig. 2,
compare C with E; compare Video 1 with 2, available at http://
jcb.org/cgi/content/full/jcb.200503152.DC1). Similar results
were obtained using either a pool of four Rac1 siRNA duplexes
or individual Rac1 siRNA duplexes to reduce Rac1 activity
(compare Fig. 2 with Fig. S3 A). Based on 11 independent ex-
periments with primary human fibroblasts, a modest reduction
in total Rac activity to 70% of original levels substantially en-
hanced directional persistence of migration, and 60% or lower
levels produced maximal directionally persistent migration
(Fig. 2 F). Conversely, overexpression of wild-type Rac1 or
constitutively activated Rac1 in primary human fibroblasts pro-
moted random cell migration with only minimal effects on
overall velocity (Fig. S3, C and D). Using an independent ap-
proach to altering Rac activity, the Rac GEF inhibitor NSC
23766 reduced concentrations of active Rac in human fibro-
blasts and produced a loss of random motility with movements
restricted to the long axis of the cells, followed by immobiliza-
tion at high doses (unpublished data).
 
Regulation of directional persistence is 
specific to Rac
 
Cdc42 regulates filopodia formation (Nobes and Hall, 1995),
and although it is involved in determining cell polarity (Nobes
and Hall, 1999; Palazzo et al., 2001; Etienne-Manneville and
Hall, 2003) and in regulating the directional migration of as-
trocytes in serum-free culture (Etienne-Manneville and Hall,
2001), knockdown experiments in human fibroblasts to selec-
tively suppress Cdc42 levels and activity produced no loss of
directional persistence of migration. Reducing the level of fi-
broblast Cdc42 protein and activity by 
 
 
 
80% did not change
Rac or Rho activity and also did not change either directional-
ity or velocity of migration (Fig. 3, A and C, and not depicted).
Rho stimulates cell contractility and adhesion by inducing the
formation of actin stress fibers and focal adhesions, inhibition
of Rho suppresses cell migration, and Rho can also affect di-
rectional persistence of migration in an epithelial cell system if
cells express 
 
 
 
1
 
 rather than 
 
 
 
3
 
 integrins (Allen et al., 1998; Rid-
ley et al., 2003; Danen et al., 2005). Although knocking down
the RhoA level in human fibroblasts by 
 
 
 
60% slowed migra-
tion speed by 40%, again there was no effect on Rac activity
or on directionality, and the D/T ratio remained unchanged
(Fig. 3, B and D). In addition, knockdown of Rac1 activity
was not accompanied by any changes in the levels of 
 
 
 
1
 
 or 
 
 
 
3
 
integrins (Fig. S4 A, available at http://jcb.org/cgi/content/
full/jcb.200503152.DC1), ruling out a mechanism involving
integrin switching. Thus, only the overall levels of Rac activ-
ity could be linked specifically to the regulation of random
versus directionally persistent migration under regular cell
culture conditions.
 
Persistence of directional migration in 
epithelial and malignant cells
 
The mode of cell migration was found to depend on the relative
level of Rac activity for two other types of cells (Fig. 4). After
siRNA-induced reduction of Rac activity in the nontrans-
formed human epithelial cell line MCF-10A, directional persis-
tence was markedly increased (Videos 4 and 5, available at
http://jcb.org/cgi/content/full/jcb.200503152.DC1) with the
D/T ratio increasing threefold (Fig. 4, A and B). In addition,
Figure 2. Suppression of Rac1 expression lowers Rac activity and inhibits
random motility of fibroblasts. (A) Primary human fibroblasts were trans-
fected with 1 nM Rac1 siRNA or 1 nM nonspecific control pool siRNA
(Contr). Pull-down assays were performed as described for Fig. 1 after 72 h
of siRNA treatment, using an immunoblot of lysates for actin to verify
equal protein loading. The amount of active Rac (Rac-GTP) was reduced to
67% of original levels and the total amount of Rac protein (total-Rac) was
reduced to 52% after this Rac1 siRNA transfection. In contrast, levels of
active Cdc42 and Rho did not change. The immunoblot for total Rac was
stripped and reprobed for total Cdc42 protein, which was not altered by
the Rac1 siRNA. (B and D) Composite collection of representative migra-
tion tracks of human fibroblasts starting 72 h after transfection with control
compared with either 0.1 or 100 nM Rac1 siRNA, respectively, tracked at
15-min intervals over a span of 10 h. Bars, 100  m. (C and E) Quantifica-
tion of persistence of migratory directionality (D/T) and velocity of the
transfected cells at the two different siRNA concentrations: (C) 0.1 nM and
(E) 100 nM. Error bars indicate SEM; the differences between control and
0.1 nM or 100 nM Rac1 siRNA D/T values were significant at the P  
0.001 level. (F) Increases in D/T ratios by reduction of active Rac using
Rac siRNA were observed in all (11 out of 11) independent experiments,
each testing three siRNA concentrations against the control. All data
were pooled together for this composite graph based on video time-lapse
microscopy on a total of 933 cells. 
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the tumor cell line U87-MG also showed enhanced directional
persistence of migration (Videos 6 and 7, available at http://
jcb.org/cgi/content/full/jcb.200503152.DC1) with a 74% in-
crease in the D/T ratio after Rac knockdown (Fig. 4, A and C).
The three cell types showed minimal to moderate decreases in
migration speed after partial Rac suppression. However, strong
reductions in Rac activity resulted in the suppression of lamella
formation and the failure of cells to migrate as noted in many
other studies (Nobes and Hall, 1995; Allen et al., 1998; Glo-
gauer et al., 2003; Pradip et al., 2003; unpublished data).
 
Biological mechanism of Rac regulation
 
The cell biological mechanism underlying this Rac-dependent
regulation of migration became apparent from time-lapse
video recordings, where each change in the direction of migra-
tion was accompanied by a change in the leading edge of the
cell: a new lamella elsewhere on the cell became dominant
(Fig. 5 A). In contrast, cells with reduced active Rac were
more elongated and had lamellae confined to only one or both
ends of the cell. We tested the hypothesis that Rac1 regulates
peripheral versus such axial lamellae by quantifying these lo-
comotory structures. Staining of F-actin with phalloidin al-
lowed us to identify morphologically distinct, ruffling lamellae
(Wu et al., 2003; Fig. S4, available at http://jcb.org/cgi/
content/full/jcb.200503152.DC1). The presence of lamellae at
an end of the long axis of the cell (within 20
 
 
 
 of the longest di-
mension of each cell) was compared with the number of more pe-
ripheral lamellae located outside of this central zone (Fig. 5 B).
Figure 3. Suppression of Cdc42 or RhoA expression does not affect di-
rectional persistence of cell migration. (A and B) Specificity of Cdc42 and
RhoA knockdowns. (A) 3 d after transfection of primary human fibroblasts
with 100 nM Cdc42 siRNA, total Cdc42 protein levels were assayed by
Western blotting with antibodies against Cdc42 in lysates of the trans-
fected (Cdc42) and control cells treated with nonspecific siRNA (Control).
Cdc42 siRNA led to a substantial decrease of both Cdc42 protein levels
(total-Cdc42) and Cdc42 activity (Cdc42-GTP) by pull-down assay,
whereas the activity and total amount of Rac in the same lysates (Rac-GTP
and total-Rac) were not affected. (B) Primary human fibroblasts were trans-
fected with 100 nM RhoA siRNA (RhoA) or nonspecific siRNA (Control).
3 d later, Rho protein levels were determined by Western blotting with an-
tibodies against Rho. Although the levels of other Rho family members
were not affected, the amount and activity of RhoA were substantially de-
creased. (C) After knockdown of Cdc42 by  80%, there were no signifi-
cant changes in the D/T directionality ratio (D/TControl   0.46   0.03 and
D/TCdc42   0.46   0.05; PD/T   0.89) or the velocity (VContr   44.4  
3.9  m/h and VCdc42   38.6   2.1  m/h; PV   0.18). (C and D) Error
bars represent the SEM. (D) Suppression of RhoA expression affects the ve-
locity of migration but not directionality. After reducing RhoA levels by at
least 60% using siRNA, velocity of cell migration was reduced by 40%
(VContr   34.4   2.4  m/h and VRhoA   20.8   1.4  m/h; P   0.0001),
but directional persistence of migration was unaffected (D/TControl   0.44  
0.03 and D/TRhoA   0.42   0.03; P   0.74).
Figure 4. Suppression of Rac1 results in increased directional persistence
of migration in human epithelial and glioblastoma cells. (A) Comparison
of total and active Rac levels in three cell lines and effects of knockdown
by Rac1 siRNA. Primary human foreskin fibroblasts (HFF), U87-MG hu-
man glioblastoma cells, and MCF-10A human mammary epithelial cells
were transfected with 50 nM Rac1 pool siRNA or control siRNA, and then
assayed for total and active Rac levels. (B) MCF-10A cells transfected with
Rac1 siRNA migrate with much higher directional persistence with no
change in velocity. MCF-10A cells were transfected with 50 nM Rac1 or
control siRNA, detached with trypsin 72 h after transfection, replated at
single-cell density, and recorded by time-lapse video microscopy. Suppres-
sion of Rac1 expression (Rac1 siRNA) induced straightening of cell migra-
tion tracks when compared with the cells transfected with the nonspecific
siRNA (Control siRNA). Bar, 100  m. The quantified directionality of
Rac1 siRNA transfected cells (Rac1) increased threefold compared with
cells transfected with control siRNA (Contr) (D/TControl   0.26   0.02 vs.
D/TRac1   0.76   0.05; P   0.0001), whereas the velocities remained
comparable (VContr   15.3   0.8  m/h vs. VRac1   15.7   1.3  m/h;
P   0.79). (C) U87-MG cells transfected with Rac1 siRNA lose random
motility and migrate with greater directionality. U87-MG cells were trans-
fected with 200 nM Rac1 siRNA, and after 3 d, cell migration was re-
corded. Bar, 100  m. Rac1 suppression resulted in a significant increase
in directionality (D/TControl   0.31   0.03 vs. D/TRac1   0.54   0.04; P  
0.0001) and a slight decrease in velocity (VContr   31.6   1.0  m/h vs.
VRac1   25.5   1.6  m/h; P   0.005).RAC SWITCH FOR CELL MIGRATION • PANKOV ET AL. 797
Knockdown of Rac1 strongly inhibited only the formation of
peripheral lamellae. There were threefold fewer peripheral
lamellae per cell and a fivefold reduction in lamellar mem-
brane; i.e., the total length of cell membrane associated with
these structures per cell (Fig. 5 C). In contrast, there were no
detectable effects of Rac reduction on lamellae located at the
ends of the long axis of cells, as determined both by the num-
ber of lamellae per cell and by the total length of lamella mem-
brane (Fig. 5 C). As a direct consequence of this selective loss
of peripheral lamellae, the total number of lamellae per cell
was reduced by half, and overall lamella length was decreased
by 57% in human fibroblasts with Rac1 knockdown and by
66% in the integrin mutant cells (Table I). Restoration of Rac
activity levels in the integrin mutant cells by expression of ac-
tivated Akt restored normal numbers of lamellae and lamellar
length, whereas overexpression of activated Rac1 enhanced
numbers of lamellae and length accompanied by an elevation
of random motility as reflected by a low D/T ratio (compare
Table I and Fig. 1, D and E, with Fig. S1 C and Fig. S3 D).
Collectively, these results demonstrate that active Rac induces
random motility by promoting peripheral lamellae oriented in
directions different from the direction of migration along the
main cell axis.
Chemotactic-directed migration versus 
intrinsic persistence of directional 
migration
We compared this mechanism of Rac regulation of directional
persistence with chemotaxis-induced directed cell migration.
Chemotactic migration is known to be regulated by PI3K
and localized phosphatidylinositol lipids (Haugh et al., 2000;
Srinivasan et al., 2003; Sasaki et al., 2004; Van Haastert and
Devreotes, 2004). We confirmed that for human fibroblast
chemotaxis toward fMLP (N-formyl-Met-Leu-Phe), inhibi-
tion of PI3K by LY 294002 with a loss of PIP3 localization, as
detected by a fluorescent pleckstin homology domain probe,
inhibited chemotaxis (Fig. 6, A and B). In marked contrast,
inhibition of PI3K did not suppress—and, in fact, moderately
promoted—intrinsic directionally persistent migration (Fig. 6
D). This increased directionality was associated with a 30–
40% decrease in Rac activity (Fig. S2 B). Similar results to
those were obtained with U87-MG glioblastoma cells treated
with Wortmannin (unpublished data). Importantly, cells ex-
hibiting increased directional persistence of migration be-
cause of active Rac1 reduction by siRNA treatment showed
no loss of directionality after inhibition of PI3K and loss of
PIP3 localization (Fig. 6 D), even though chemotaxis was
blocked. Neither suppression of Rac activity nor treatment
with LY 294002 had a significant effect on activation-associ-
ated phosphorylation of the MAP kinases ERK1/2 and JNK
(Fig. S2). Consistent with previous data establishing a role
for Cdc42 in chemotactic-directed migration, suppression of
Cdc42 levels and activity by  80% suppressed fibroblast
chemotaxis (Fig. 6 C).
Figure 5. Suppression of Rac reduces the number of
peripheral lamellae and changes in direction of cell
migration. (A) Primary human fibroblasts transfected
with control or Rac1 siRNA were recorded by time-
lapse video microscopy. Phase-contrast micrographs
and migration paths of two representative cells are
shown at 1-h intervals. Green arrowheads indicate
lamellae extending in the direction of cell movement.
Yellow arrowheads show lamellar protrusions in other
directions. Green arrows in the diagrams to the right
of the micrographs indicate the direction and distance
of cell movement each hour. (B and C) Quantifica-
tion of Rac-dependent lamellae in an axial versus a pe-
ripheral location. The main cell axis was determined
as the longest distance between the ends of each cell
(continuous red line in the image of a cell stained for
F-actin). Two zones were defined as follows: “axial”
was within 20  of the main axis (area between the
dashed white lines) and “peripheral” was anything lat-
eral to this zone. The length of total membrane in all
lamellae of each cell and the number of lamellae per
cell were determined for axial (green) compared with
peripheral (yellow) lamellae in cells transfected with
control (Contr) and Rac1 (Rac1) siRNA and presented
as mean values   SEM. Bar, 20  m.
Table I. Rac-dependent changes in lamellae
Cell line/clone
Lamella
length/cell Lamellae/cell
 m
GD25  1 wild-type 51.0   2.5 2.8   0.1
GD25 W775A 17.1   1.5 1.6   0.1
GD25 W775A Akt 1 29.9   1.9 2.1   0.1
GD25 W775A Akt 2 53.0   3.9 2.6   0.2
GD25 W775A Akt 3 56.1   2.5 2.8   0.1
GD25 W775A Rac 1 94.1   5.6 3.5   0.1
GD25 W775A Rac 2 105.5   5.0 2.9   0.1
GD25 W775A Rac 3 95.9   4.4 3.4   0.1
HFF control siRNA 52.0   2.0 3.7   0.1
HFF Rac1 siRNA 22.1   2.0 2.0   0.1
The length and number of lamellae per cell were measured for at least 45 cells
from each cell line/condition and quantified by image processing software
(MetaMorph version 4.6). Values represent mean   SEM.
HFF, primary human foreskin fibroblasts.JCB • VOLUME 170 • NUMBER 5 • 2005 798
Rac and migration in 3D matrix
Cells migrating in 3D cell-derived matrices have different
types of cell adhesions, morphology, and signaling when com-
pared with cells in standard 2D tissue culture (Cukierman et al.,
2001; Walpita and Hay, 2002). Human fibroblasts in such 3D
matrices were found to have a partial, but highly reproducible,
30–50% reduction in active Rac, but no reduction or increase in
Cdc42 or Rho activities (Fig. 7 A). This reduction in Rac activ-
ity was accompanied by decreased random migration (Fig. 7 C
and Video 3), with directional persistence increasing from
D/T2D   0.48   0.03 to D/T3D   0.87   0.02 (P   0.0001).
Individual cells in the 3D matrix became spindle shaped as pre-
viously described (Cukierman et al., 2001), but in addition,
staining for F-actin revealed a substantial reduction in periph-
eral lamellae in 3D compared with 2D (Fig. 7 B). In contrast to
the results in cells cultured on 2D substrates, there was a signif-
icant increase in overall cell migration velocity by 34% associ-
ated with the reductions in active Rac and random migration in
a 3D environment (Fig. 7 C; P   0.0001). These findings fur-
ther indicate the separate regulation of speed and directionality.
Because the differences between 2D fibronectin and 3D
substrates could have been the result of either three dimension-
ality or of differences in molecular composition, the 3D matrix
was converted to 2D as a direct test of the role of dimensionality.
Physically flattening 3D cell-derived matrices by compression
still retained the increased overall velocity, but it was accom-
panied by a restoration of random motility (Fig. 7 D; P  
0.0001). Moreover, solubilizing the matrix and spreading its
mixed components on a 2D substrate showed the same restora-
tion of random motility (Fig. 7 D; P   0.0001), with migration
rates similar to those on 3D matrix (no statistically significant
difference). These analyses indicate that the increased direc-
tionality in 3D is related to the three dimensionality of the
matrix, and that it is unrelated to cell migration speed.
A highly oriented 3D matrix, such as from tumor-derived
stromal cells, can affect the orientation and potentially the migra-
tion of cells (Amatangelo et al., 2005). Although local parallel
alignment and migration of closely adjacent cells was sometimes
present in our 3D matrix cultures, there was no general pattern
of parallel migration. Persistence of migration occurred in all di-
rections in the 3D matrix (Fig. S5, A and B, available at http://
jcb.org/cgi/content/full/jcb.200503152.DC1). Finally, directly
Figure 6. Inhibition of PI 3-kinase or Cdc42 inhibits chemotaxis but not
directionally persistent cell migration. (A) Inhibition of PI3K by 50  M LY
294002 blocks primary human fibroblast chemotaxis toward 300 nM
fMLP whether or not Rac is suppressed by 1 nM Rac1 siRNA. (B) Localiza-
tion of GFP-tagged Akt PH domain to lamellae is suppressed by treatment
with LY 294002. Insets show lower magnification views of the entire cell.
Bars, 20  m. (C) Inhibition of Cdc42 by 100 nM Cdc42 siRNA ( 80% of
both total Cdc42 protein and activity) blocks fMLP-stimulated chemotaxis
of human fibroblasts. (D) Inhibition of PI3K by 50  M LY 294002 does
not suppress the increased directional persistence of migration induced by
reduction of active Rac using 1 nM Rac1 siRNA. (A, C, and D) Error bars
represent SEM.
Figure 7. 3D fibronectin matrix reduces both Rac activity and random
migration. (A) Primary human fibroblasts were plated on 2D substrates
coated with fibronectin or 3D matrices rich in fibronectin and assayed for
activity as in Fig. 1. The reduction of active Rac in cells plated in a 3D ma-
trix compared with 2D was 31% (P   0.017), whereas Cdc42 and Rho
changes were not significant (Cdc42 4.5% reduction, P   0.66; Rho 25%
increase, P   0.65). Error bars indicate SEM. (B) Cells in 2D versus 3D
environments have different morphologies and locations of lamellae (ar-
rowheads), as shown after staining for F-actin with phalloidin-Alexa 594
(left and red color in the right) and anti-fibronectin antibody (green). Bar,
20   m. (C) Migration of cells in 2D versus 3D environments was re-
corded, and directionality (D/T) and velocity were calculated. (C and D)
Error bars represent SEM. (D) Decreased random motility of cells within
three-dimensional (3D) matrix. Primary human fibroblasts were cultured
overnight within intact 3D matrices, on mechanically flattened 3D matrix
(2D matrix), or on surfaces coated with solubilized 3D matrix (2D mix).
Cell movements were recorded for 10 h, and the D/T ratio and velocity
were calculated as described above. (E) Activated Rac in cells in 3D ma-
trix restores random motility. Primary human fibroblasts were cotrans-
fected with Rac Q61L VSV and Rac Q61L GFP or GFP alone (Control),
sorted for low levels of GFP expression (1–50% from the peak of positive
cells), and plated on 3D matrices. Cell movements were recorded for 10 h,
and the D/T ratio and velocity were quantified. The bars represent the
means of data pooled from two experiments, and error bars indicate SEM
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increasing Rac activation levels by transfection with constitu-
tively activated Rac produced an increase in random motility
in the 3D matrix with a 30% decrease in the D/T ratio (Fig. 7 E;
P   0.001)) and increased lamellae (not depicted), confirm-
ing that Rac confers random motility in a 3D as well as in a
2D environment.
Discussion
Our central finding is that a relatively small change in total
Rac1 activity can serve as a switch that regulates the overall
intrinsic pattern of cell migration of a cell. By using at least
three different approaches (mutagenesis, RNA interference,
and manipulation of the extracellular environment between 2D
and 3D), we demonstrate that moderate levels of active Rac
support random motility by selectively promoting peripheral
lamellae that permit cell turning, but reductions of active Rac
by   30% instead support directionally persistent migration
using axial lamellae.
This role of Rac in regulating the capacity for random
versus directionally persistent motility was found for a variety
of cell types, including fibroblasts and epithelial cells, suggest-
ing that it is a common phenomenon. Moderate changes in Rac
activity did not necessarily affect the velocity of cell migration,
and in a 3D environment, suppression of Rac activity occurred
together with increased velocity, indicating the independence
of directionality from velocity. Primary human fibroblasts ex-
press Rac1 and traces of Rac2 and Rac3 (unpublished data); it
is possible that reductions in Rac1 were able to produce such
large effects on the mode of migration without changes in over-
all migration velocity because other Rac isoforms or other reg-
ulators of migration speed were still present. Unlike velocity,
directionality strongly depended on cellular levels of Rac-GTP
and not Cdc42 or Rho.
In terms of a cell biological mechanism, slightly lowering
Rac1 activity resulted in suppression of peripheral lamellae,
which promoted persistent migration of a cell in one direction
because of the absence of new peripheral lamellae that could
produce a change in the direction of cell migration. This regu-
lation of intrinsic directionality differs markedly from chemo-
tactic-directed migration, which depends on PI3K and local-
ized PIP3 with Rac or Ras localization to active lamellae
(Srinivasan et al., 2003; Sasaki et al., 2004; Van Haastert and
Devreotes, 2004). It also differs from mechanisms involving
local changes in Rac activity during chemotaxis and  4 inte-
grin–regulated migration (Arrieumerlou and Meyer, 2005;
Nishiya et al., 2005).
In contrast to this novel role of small changes in total Rac
activity in regulating the overall pattern of cell migration, sub-
stantial increases in Rac activity are well-known stimulators of
the velocity of cell migration (Etienne-Manneville and Hall,
2002; Raftopoulou and Hall, 2004). Conversely, cells with ma-
jor deficiencies in Rac as a result of gene ablation or RNA in-
terference are reported to show marked defects in overall cell
migration and chemotaxis (Roberts et al., 1999; Glogauer et al.,
2003; Sun et al., 2004; Weiss-Haljiti et al., 2004). Rac activation
is accompanied by its translocation to the plasma membrane
(del Pozo et al., 2002, 2004), with the highest concentrations of
active Rac located at the leading edge of motile cells (Kraynov
et al., 2000; Itoh et al., 2002; Schlunck et al., 2004). Active Rac
in lamellipodia at the leading edge is thought to function by
interacting with WAVE to stimulate Arp2/3-mediated actin
polymerization, producing lamellar extension and forward cell
movement (Miki et al., 2000; Pollard et al., 2000). However,
cell migration can still proceed effectively in the absence of
lamellipodia (Gupton et al., 2005), suggesting that the target of
Rac may be the lamella rather than lamellipodia. We empha-
size again that our studies have focused on the role of total or
global levels of cellular Rac1 activity as a central regulator,
rather than on localized Rac.
Our findings indicate that Rac1 levels regulate persis-
tence of migration by controlling the number of peripheral
lamellae and associated total amount of membrane protrusions
that can mediate cell turning (3–5-fold difference), whereas the
number of axial lamellae and associated protrusive membrane
located along the long axis of the cell did not change (1–1.1-
fold dfference). The original concept of the dominance of, first,
one, and then another lamella during cell migration, which ex-
plains the capacity of fibroblasts and other cells to turn and
migrate in a new direction, has been known for decades
(Trinkaus, 1969). Our study describes a signaling process that
limits the number of peripheral lamellae used for turning.
Studies of Rac and other Rho GTPases have traditionally
depended heavily on overexpression of constitutively activated
and dominant-negative constructs. Although useful for manip-
ulating levels of activity, they could theoretically be accompa-
nied by artifacts because the GTPase does not cycle or the
construct might affect an unknown range of regulatory mole-
cules. In fact, we found that strong overexpression of both
types of constructs to produce a large suppression or enhance-
ment of Rac activity disrupted cell migration with a substantial
decrease in velocity, which is consistent with previous studies
(Nobes and Hall, 1995; Allen et al., 1998; Banyard et al., 2000;
Glogauer et al., 2003; Pradip et al., 2003). As alternative ap-
proaches, our use of an integrin mutant, RNA interference to
produce stepwise reductions in total Rac activity, comparisons
with other Rho GTPases, testing the effects of physiological
changes in the type of substrate on Rac and migration pattern,
and the use of a Rac small-molecule inhibitor were designed to
provide independent tests of the role of Rac activity in the pat-
tern of cell migration. All of these independent approaches
support the central role of the total Rac activity in regulating
random versus directionally persistent migration.
As depicted in Fig. 8, we suggest that there may be at
least four distinct levels of Rac activity differentially regulating
the speed and pattern of intrinsic cell migration. As described
by others (e.g., Glogauer et al., 2003), very low levels of active
Rac result in immobilization of the cells (Fig. 8, state I). Natu-
rally occurring levels of active Rac higher than this extreme
state, but still  30–50% lower than in cells cultured on a 2D fi-
bronectin substrate, were found in fibroblasts grown in 3D
(Fig. 8, state II). Under these conditions, cells retained a spin-
dle-shaped morphology, but developed a stable, single lamella
in the direction of migration containing membrane-localizedJCB • VOLUME 170 • NUMBER 5 • 2005 800
Rac1. These state II cells demonstrated both the highest direc-
tionality and highest velocity of migration. We suggest that this
condition would be ideal for cell migration in vivo; e.g., during
neural crest and myoblast cell migration in embryonic develop-
ment. Elevation of Rac levels by extrinsic or intrinsic factors
could disrupt these processes. In addition, our finding that
chemotaxis can be stimulated by a moderate reduction in Rac
suggests that the specific level of overall Rac activation may
also influence chemotactic efficiency in vivo.
The low random motility of state II cells in 3D could be
mimicked by suppressing active Rac in cells in 2D cultures
30–95% below steady-state levels. Levels of active Rac found
normally in cells attached to 2D plastic or fibronectin-coated
substrates in regular tissue culture promoted the formation of
peripheral lamellae and led to an increased random migration
(Fig. 8, state III). Random migration could also be induced in
state II cells in 3D matrices by the experimental elevation of
Rac. At very high levels of Rac-GTP accompanying constitu-
tive activation, cells acquired rounded nonruffling or pancake-
shaped, highly ruffled morphologies, and they became immobi-
lized (Fig. 8, state IV). This state might occur during initial
cell spreading when cells show transient Rac activation (Price
et al., 1998) without migration. The key finding, however, is
that relatively small changes in total Rac can serve as a central
regulator of intrinsic random versus directionally persistent
cell migration.
Materials and methods
Cell culture
Primary human foreskin fibroblasts were a gift from Susan Yamada (Na-
tional Institute of Dental and Craniofacial Research [NIDCR], Bethesda,
MD) and were used at passages 5–18. The GD25  1-null fibroblast cell
line was a gift from R. Fässler (Max Planck Institute, Martinsried, Ger-
many). GD25 cells expressing wild-type or mutant  1 integrin were gen-
erated as described previously (Pankov et al., 2003). U87-MG human
glioblastoma and MCF-10A human breast epithelial cell lines were origi-
nally purchased from American Type Culture Collection. All cell lines ex-
cept MCF-10A were cultured in DMEM containing 10% FBS, 100 U/ml
penicillin, and 100  g/ml streptomycin. MCF-10A cells were cultured in
DMEM/Ham’s F12 medium supplemented with 20 ng/ml EGF, 10  g/
ml insulin, 500 ng/ml hydrocortisone, and 5% equine serum. 3D fi-
bronectin-containing matrices were prepared as described previously
(Cukierman et al., 2001).
A 3D matrix on a coverslip was mechanically compressed by ap-
plying a weight of 940 g to a central area of 625 mm
2 (1.5 g/mm
2) for 5
min to generate a 2D matrix (Cukierman, 2002). Alternatively, 3D matri-
ces were solubilized in 5 M guanidine containing 10 mM DTT and 5 mM
PMSF. The dissolved matrix components were coated on tissue culture
dishes at a protein concentration of 50  g/ml.
Antibodies and reagents
Antibodies to total-, phospho (Ser 473)-, and phospho (Thr 308)-Akt as
well as total, phospho (Thr 202), and (Tyr 204) p44/42 MAP kinase
(ERK1/2) were purchased from Cell Signaling; anti-Cdc42 antibody was
purchased from BD Biosciences; phalloidin conjugated with Alexa 488 or
Alexa 594 was obtained from Molecular Probes; total, phospho (Thr
183), and phospho (Tyr 185) JNK antibodies, Cdc42 siRNA sc29256,
and RhoA siRNA sc29471 were obtained from Santa Cruz Biotechnol-
ogy, Inc.; anti-RhoA antibodies were purchased from Santa Cruz Biotech-
nology, Inc. or Cytoskeleton, Inc.; anti-VSV epitope and antiactin clone
AC-40 were purchased from Sigma-Aldrich; anti-Rac antibody and Rho-
tekin-Rho binding domain were purchased from Upstate Biotechnology or
Cytoskeleton, Inc.; anti- 1 antibody 4080 was raised against a 50-mer cy-
toplasmic domain peptide in a rabbit; and anti- 3 integrin hybridoma AP3
was purchased from American Type Culture Collection. PAK1 PBD aga-
rose was purchased from Upstate Biotechnology or Cytoskeleton, Inc. Rac1
siRNA and the nonspecific control siRNA pool were obtained from Dhar-
macon. The individual sequences (sense) for each Rac1 siRNA duplex
were as follows: 5, AGACGGAGCUGUAGGUAAAUU; 7, UAAGGAGA-
UUGGUGCUGUAUU; 8, UAAAGACACGAUCGAGAAAUU; and 9 (with
ON TARGET™ modification for enhanced specificity), CGGCACCACU-
GUCCCAACAUU. These siRNAs were used either as a pool of all four or
as individual siRNA duplexes.
The Rac inhibitor NSC23766 was recently reported (Gao et al.,
2004) to be a Rac-specific small-molecule inhibitor that targets Rac activa-
tion by GEF. The compound was designed, synthesized, and provided by
the Drug Synthesis and Chemistry Branch (National Cancer Institute, Be-
thesda, MD). LY 294002 was purchased from Calbiochem.
Plasmids
An expression plasmid containing cDNA encoding the small GTPase Rac1
was provided by J. Silvio Gutkind (NIDCR). The constitutively activated
Rac1 construct pRK VSV RacQ61L (Rac QL) with a VSV epitope tag was de-
scribed previously (Koivisto et al., 2004). A cDNA clone encoding Akt was
purchased from Upstate Biotechnology. For constitutive activation, the myris-
toylated vector pRKmyr was constructed by inserting the Kozak consensus
sequence and the 13 NH2-terminal amino acids of c-Src into the pRK5-
based expression system. BamHI and XbaI sites were introduced into Akt us-
ing PCR, and Akt was subcloned into pRKmyr to obtain pRKmyrAkt. HindIII
and SalI sites were introduced by PCR to flank the Akt PH domain (aa
1–148), and the PH domain was subcloned into pEGFP-C1 to generate the
pEGFP-C1Akt-PH probe (Kontos et al., 1998; Servant et al., 2000).
siRNA transfection, pull-down assays, and immunoblotting
Primary human fibroblasts were transfected with 0.01–200 nM siRNA us-
ing Lipofectamine 2000 (Invitrogen) and OptiMEM medium (GIBCO BRL)
in the absence of antibiotics according to the manufacturer’s recommen-
dations. Transfected cells were passaged at 56–60 h and used after 72 h.
Transfection efficiency as determined by fluorescence detection of Dhar-
macon siGLO RISC-free siRNA at transfection concentrations ranging from
0.01 to 100 nM was 100% at all of these concentrations tested. Pull-down
assays for Rho-GTPases were performed as described previously (Sander
et al., 1998) with minor modifications. In brief, cells were scraped into
ice-cold lysis buffer (25 mM Hepes, pH 7.5, 150 mM NaCl, 10 mM
MgCl2, 1 mM EDTA, 1% Igepal, 10% glycerol, and Complete™ protease
Figure 8. Four stages of Rac-GTP regulation of cell morphology
and types of cell motility. The amount of Rac localized in lamel-
lae as shown by anti-Rac1 antibody localization (left) and de-
picted schematically in the diagram (red) with increasing levels
of Rac activation (broad gray arrow) from state I to state IV. In-
creased levels of total cellular active Rac produce characteristic
increases in the extent of random cell motility accompanied by
varying velocities of cell migration in 2D versus 3D culture or af-
ter experimental manipulations of Rac activity. Rac activation
that is too low or too high leads to immobilization, with stunted
lamellae at low levels and continuous, circumferential lamellae or
cell rounding at very high levels (Discussion). The cells shown in
the examples were primary human fibroblasts stained for Rac1
after culturing on a 2D substrate (state III) or in a 3D matrix (state II) compared with effects of extensive knockdown of Rac1 using 200 nM Rac siRNA
(state I) or overexpression of constitutively activated Rac QL after transient transfection (state IV).RAC SWITCH FOR CELL MIGRATION • PANKOV ET AL. 801
cocktail without EDTA [Roche]), and centrifuged for 5 min at 14,000 g.
Cleared lysates were incubated with 10 or 20  g PAK-1 PBD agarose or
20  g GST-tagged Rhotekin Rho-binding domain bound to glutathione
agarose for 45 or 60 min at 4 C with rotation. The beads were washed
three times with lysis buffer and heated for 3–5 min at 95–100 C in reduc-
ing SDS-PAGE sample buffer, and the released proteins were resolved on
8–16% gradient gels (Novex). After electrotransfer to nitrocellulose mem-
branes (Novex), the filters were blocked (5% nonfat dry milk in 150 mM
NaCl, 50 mM Tris-HCl, pH 7.4, and 0.1% Tween 20) and probed with
the indicated antibodies, followed by the appropriate secondary horse-
radish peroxidase-conjugated antibodies (Amersham). Immunoblots were
visualized using the ECL system and Hyperfilm X-ray film (Amersham Bio-
sciences). For experiments quantifying the effects of different levels of active
Rac on the D/T ratio, immunoblots were analyzed by using a chemilumi-
nescent imager (LAS-1000 Pro V3.12; Fuji) after development with the
Super Signal West Femto Maximum Sensitivity Substrate (Pierce Chemical
Co.); results were quantified using Image Gauge V4.22 software (Fuji).
All pairs or sets of gel images used samples that were analyzed on the
same polyacrylamide gel.
Microscopy
Cells were plated on tissue culture dishes with or without precoating with
1 or 5  g/ml human plasma fibronectin or onto 3D fibronectin-containing
matrices at a density of 500 cells/cm
2. After overnight incubation, the me-
dium was changed, and cell movements were monitored with microscopes
(Axiovert 25; Carl Zeiss MicroImaging, Inc.) using 5  NA 0.12 or 10 
NA 0.25 A-Plan objectives. Images were collected with CCD video cam-
eras (model XC-ST50; Sony) at 10- or 15-min intervals, digitized, and
stored as image stacks using MetaMorph 6.16 software (Universal Imag-
ing Corp.). Velocity and persistence of migratory directionality (D/T) were
determined by tracking the positions of cell nuclei using the Track Point
function of MetaMorph. Control experiments indicated that the D/T ratio
was the same for the first and second halves of the analysis period (Fig.
S5 C, and that the 10–15-min rate of acquisition of images was sufficient
to minimize the asymptotic approach to a constant D/T ratio that can oc-
cur if sampling was conducted at 1-h intervals (Fig. S5 D). The mean
square displacement values were obtained using the Track Object func-
tion, which determined the intensity centroids of the defined target regions
(i.e., the cells) and tracked their displacement automatically through the
planes of each image stack.
Cells for immunofluorescence analysis were plated on uncoated or
fibronectin (5  g/ml) or 3D matrix precoated glass coverslips (12 mm;
Carolina Biological Supply Company) and cultured overnight. Samples
were fixed with 4% PFA in PBS containing 5% sucrose for 20 min and
permeabilized with 0.5% Triton X-100 in PBS for 3 min. Samples were
stained with phalloidin that was conjugated with Alexa 488 or Alexa
594 as recommended by the manufacturer. Stained samples were
mounted in GEL/MOUNT (Biomeda Corp.) containing 1 mg/ml 1,4-phe-
nylendiamine (Fluka) to reduce photobleaching. Immunofluorescence im-
ages were obtained using 40  NA 1.0 or 63  NA 1.5 oil immersion
objectives of a microscope (Axiophot; Carl Zeiss MicroImaging, Inc.)
equipped with a CCD camera (CoolSNAP ES; Photometrics). Digital im-
ages were obtained using MetaMorph 6.16 software. Each figure shown
is representative of a minimum of two to three independent experiments
analyzing 30–45 cells each.
Chemotaxis assay
Primary human fibroblasts were detached with trypsin-EDTA, rinsed, and
preincubated with 50  M LY 294002 (Calbiochem) or vehicle (0.2% eth-
anol) in complete medium for 15 min in suspension before plating. Cells
(8   10
4) were plated onto a Transwell system insert (8- m pore size; BD
Falcon) in a 6-well plate and placed in 3 ml of complete medium with or
without 300 nM fMLP (Sigma-Aldrich), LY 294002, or vehicle. Cells were
incubated at 37 C for 2 h, and then the inserts were washed with PBS and
fixed with 2% PFA in PBS. Cells were removed from the top part of the
membrane, and the cells that had migrated to the bottom of the membrane
were counted using a phase-contrast microscope. The mean number of
cells per field   SEM of five randomly chosen fields was calculated for
each condition.
Online supplemental material
Fig. S1 shows directionally persistent migration of mutant integrin cells
and suppression by expression of active Rac. Fig. S2 provides examples
of loss of both Rac protein and active Rac (Rac-GTP) after treatment with
Rac siRNA without effects on activation-associated phosphorylation of Akt,
ERK, or JNK; it also confirms activity of the PI 3 -kinase inhibitor LY
294002. Fig. S3 shows the effects on cell migration of Rac1 knockdown
by Rac1 siRNA duplexes or Rac1 overexpression. Fig. S4 shows the lack
of effects of Rac1 knockdown on integrins and morphology of cells with
an integrin mutation or Rac1 knockdown. Fig. S5 shows analysis of cell
migrations in 2D and 3D environments by time-lapse recording.
All videos show time-lapse video recordings at 10-min intervals for
12 h and were recorded using a 5  objective except for video 3, which
uses a 10  objective to show cell interactions with the pliable, randomly
oriented 3D matrix. Video 1 shows human fibroblasts migrating after
transfection with control siRNA. Video 2 shows human fibroblasts migrat-
ing after transfection with 0.1 nM Rac1 siRNA. Video 3 shows human fi-
broblasts migrating within a 3D matrix. Video 4 shows MCF-10A human
epithelial cells migrating after transfection with control siRNA. Video 5
shows MCF-10A cells migrating after transfection with 50 nM Rac1
siRNA. Video 6 shows U87-MG human glioblastoma cells migrating after
transfection with control siRNA. Video 7 shows U87-MG migrating after
transfection with 50 nM Rac1 siRNA. Online supplemental material is
available at http://jcb.org/cgi/content/full/jcb.200503152.DC1.
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